The bill aims to expand affordability and competition in health coverage—through public-plan options, reinsurance, bigger premium tax credits, and stronger antitrust enforcement—but does so at the cost of substantial new federal spending, implementation complexity, potential provider network disruptions, and possible loss of a drug-price negotiation tool.
Uninsured individuals and people with chronic conditions could gain new coverage options and more insurance choice if a publicly administered plan or expanded public-plan authority is created, potentially improving access to care.
Medicare Exchange enrollees will have more equal access to providers because plans cannot be singled out for stricter patient restrictions and discriminatory providers can be excluded from federal programs, protecting beneficiaries.
Individuals buying coverage on the individual market (including middle-class families and some uninsured people) could see more stable and potentially lower premiums because a federally funded reinsurance program pools high-cost risks nationally and provides dedicated funding.
Taxpayers could face substantially higher federal spending and upward pressure on deficits because the bill authorizes multiple new appropriations (public plan costs, $30B reinsurance, expanded tax credits, and DOJ/FTC funding).
Medicare beneficiaries and some patients could lose provider options if providers refuse to accept certain plans (to avoid new rules or enforcement), narrowing networks and access to care.
Hospitals, smaller or specialty practices, insurers and employers could face increased administrative and compliance costs (from equal-treatment requirements, subsidy calculations, antitrust compliance and reporting), which may be passed on to consumers or strain small providers.
Based on analysis of 8 sections of legislative text.
Creates a federal Medicare Exchange public plan, expands premium tax credits and affordability rules, funds a nationwide reinsurance program, removes a Medicare drug-negotiation subsection, and boosts DOJ/FTC antitrust funding.
Official title: Establish a public health plan.
Introduced December 4, 2025 by Michael F. Bennet · Last progress December 4, 2025
Creates a new federal public health plan under the Social Security Act (a Medicare Exchange public plan) and makes multiple changes to improve affordability and competition in individual health coverage. It expands premium tax credit rules, funds a nationwide reinsurance program to lower individual-market premiums, requires federal antitrust agencies to study and enforce anticompetitive practices in health care, and changes provider participation rules for the new Medicare Exchange plan. The bill also removes one subsection of the Medicare prescription drug negotiation statute, authorizes multiyear appropriations for reinsurance and antitrust work, and requires reports to Congress on antitrust activities. Some tax provisions take effect for taxable years beginning after December 31, 2025; other provisions take effect on enactment or when implemented by agencies and appropriations are provided in later fiscal years.